Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• Leukemia-initiating cells (LICs) typically have a lineage-committed phenotype, despite originating from germline or hematopoietic stem cells (HSCs).
• The molecular mechanisms driving this compartment shift during leukemia evolution are poorly understood.
• Runx1 deficiency is a frequent event in leukemia initiation.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the compartment shift of leukemia-initiating cells (LICs) during leukemia evolution.
• To examine the role of Runx1 deficiency in this process.

Main Methods:

• Lineage-negative cells from Runx1-haploinsufficient and wild-type mice were cultured to induce lineage commitment.
• Cell growth, morphology, and differentiation markers were assessed.
• RNA and protein expression of key transcription factors (Cebpa, Cebpe) and Hoxb4 were analyzed.
• Chromatin-immunoprecipitation was used to assess Runx1 binding at gene enhancers.

Main Results:

• Runx1-haploinsufficient cells exhibited greater and persistent exponential growth compared to controls.
• Impaired differentiation in Runx1-deficient cells was linked to decreased Cebpe expression, not lineage commitment.
• Runx1 deficiency reduced Runx1 binding at the Cebpe enhancer, while binding at the Cebpa enhancer was preserved.
• Primary acute myeloid leukemia cells with RUNX1 mutations showed high CEBPA and low CEBPE expression.

Conclusions:

• Runx1 deficiency promotes exponential cell growth by upregulating Cebpa and impairing Cebpe activation.
• This mechanism allows leukemia cells to maintain a lineage-committed phenotype while prolonging proliferation.
• These findings elucidate how leukemia cells evolve from stem cells to lineage-committed LICs.